. 2012 Apr 20;7(4):e34973. doi: 10.1371/journal.pone.0034973
Köhler et al.
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
Figure 1. Known and newly identified PRK1 inhibitors.
